Skip to content
POM-V Prescription Required Companion Animal

Galastop 50 ug/ml Oral Solution

Active ingredient: Cabergoline

Form

Liquid

Species

Dogs

Manufacturer

Ceva Salute Animale S.p.A

VMD MA No.

28350/4001

What it's used for

•: Suppression of lactation in the bitch may be required under certain clinical circumstances (for example following removal of puppies soon after birth, o...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Cabergoline

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Galastop 50 ug/ml Oral Solution — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

•: Suppression of lactation in the bitch may
be required under certain clinical circumstances (for example following removal
of puppies soon after birth, or following early weaning). Inhibition of prolactin
secretion by cabergoline results in a rapid cessation of lactation and a reduction
in the size of the mammary glands.
The dosage is 0.1 ml/kg bodyweight (equivalent to 5 µg/kg bodyweight of
cabergoline) once daily for 4-6 consecutive days, depending on the severity of the
clinical condition.
For dogs less than 5 kg bodyweight it is advisable to measure the dosage in drops,
3 drops being equivalent to 0.1 ml.
The solution can be given either with the dropper or the syringe.
If the signs fail to resolve after a single course of treatment, or if they recur after the
end of treatment, then the course of treatment may be repeated.
For treatment of false pregnancy clinical studies have demonstrated efficacy
between 80-100%.
Behavioural signs are alleviated first, followed by reduction in mammary gland
enlargement, then finally suppression of lactation.
• Do not use in pregnant animals since Galastop may cause abortion.
• Galastop may induce transient hypotension in treated animals. Do not use in
animals concurrently being treated with hypotensive drugs. Do not use directly
after surgery whilst the animal is still under the influence of the anaesthetic
agents.
• Do not use with dopamine antagonist.
Dogs:
Very common
(>1 animal / 10 animals treated):
Anorexia
Common
(1 to 10 animals / 100 animals
treated):
Vomiting
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Drowsiness
, muscle tremor, ataxia, twitching,
trembling
Hyperactivity, restlessness, aggression, distress,
hyperexcitation
Hypotension
Allergic reaction
Transient, usually only occur at the moment of first one or two administrations.
Transitory. See also section "Special precautions for safe use in target animal
species".
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.
Additional supportive treatments should involve restriction of water and
carbohydrate intake and increase exercise.

Special precautions for safe use in the target species:
Cabergoline has the capacity to cause abortion in bitches in the later stages of
pregnancy, and under no circumstances should Galastop be used in pregnant
bitches (see 4.3 above).
Cabergoline may induce transient hypotension in treated animals and use of
Galastop in animals concurrently being treated with hypotensive drugs, or in animals
directly after surgery whilst the animal is still under the influence of anaesthetic
agents, might result in more significant hypotension and such usage is contra-
indicated.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Avoid contact with skin and eyes. Wash off any splashes immediately.
Women of childbearing age should take care to avoid contact with the veterinary
medicinal product.
Women of childbearing age should wear personal protective equipment consisting of
impermeable gloves when handling the veterinary medicinal product.
Wash hand after use.
Special precautions for the protection of the environment:
Not applicable.
Since cabergoline exerts its therapeutic effect by direct stimulation of dopamine
receptors, Galastop should not be administered concurrently with drugs which have
dopamine antagonist activity (such as phenothiazines, butyrophenones), as these
might reduce its prolactin inhibiting effects.
Do not store above 25°C.
Protect from light.
Do not refrigerate.
Store in tightly closed original container.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.